SF Website Callout

    Widely used GLP-1 receptor agonists, commonly prescribed for type 2 diabetes and obesity, may be associated with a small increase in colorectal cancer risk, according to a recent meta-analysis discussed by oncology expert David Kerr, MD, of the University of Oxford. The analysis pooled data…

    DDW 2025

    Headlines in GI

    Subscribe to Newsletter

    * indicates required

    Thought Leadership